一塩基多型（SNP）ジェノタイピングの世界市場レポート 2024

一塩基多型（SNP）ジェノタイピングの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には19.1%の年間複合成長率（CAGR）で206億米ドルに成長すると予想されます。予測期間中に予想される成長は、疾患調査における応用の拡大、精密医療の需要の増加、バイオバンキングの取り組みの拡大、遺伝子検査の急増、作物改良のための農業での採用の増加に起因すると考えられます。予測期間中に予想される主な動向には、次世代シーケンサー（NGS）の使用増加、薬理ゲノミクスにおけるSNPジェノタイピングの需要の高まり、消費者向けの直接遺伝子検査の出現、自動化およびハイスループットのジェノタイピングプラットフォームへの注目が含まれます。

一塩基多型（SNP）ジェノタイピング市場の成長は、慢性疾患の負担の増加によって促進されると予想されます。慢性疾患は、1年以上続き、継続的な治療が必要な病気として定義され、日常生活に大きな影響を与えます。 一塩基多型（SNP）ジェノタイピングは遺伝的素因を特定する上で重要な役割を果たし、慢性疾患の蔓延の中での個別化医療の台頭に貢献しています。 2023年 1月に国立バイオテクノロジー情報センター（NCBI）が示したように、世界の慢性疾患患者の数は、2020年の7,152万2,000人から2050年までに1億4,266万人に達すると予測されています。この慢性疾患の負担の増大は、深刻な問題となっており、 一塩基多型（SNP）ジェノタイピングシステム市場の成長を推進する重要な要因です。

ゲノム調査への資金配分の増加により、一塩基多型（SNP）ジェノタイピング市場の成長がさらに促進される見込みです。ゲノム調査のための資金には、SNP研究を進めるために不可欠なゲノミクス調査活動の支援に充てられる財源が含まれます。国立ヒトゲノム調査などの組織は、2020年に6億400万米ドル、2021年に6億1,400万米ドル、2022年に6億1,600万米ドルを受け取り、2023年の予算案は6億2,900万米ドルとなっています。さらに、バイデン政権は2021年4月にSARS対策に17億米ドルを割り当てましたゲノム研究資金の増加は、一塩基多型（SNP）ジェノタイピング市場の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の一塩基多型（SNP）ジェノタイピング市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 消耗品
• 機器
• サービス
• 世界の一塩基多型（SNP）ジェノタイピング市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• TaqMan SNPジェノタイピング
• 質量アレイ SNPジェノタイピング
• SNP遺伝子チップアレイ
• その他の技術
• 世界の一塩基多型（SNP）ジェノタイピング市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 動物遺伝学
• プラントの改善
• 診断調査
• 医薬品と薬理ゲノミクス
• 農業バイオテクノロジー
• その他の用途

第7章 地域および国の分析

• 世界の一塩基多型（SNP）ジェノタイピング市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の一塩基多型（SNP）ジェノタイピング市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 一塩基多型（SNP）ジェノタイピング市場の競合情勢
• 一塩基多型（SNP）ジェノタイピング市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Roche Diagnostics Corporation
  • GE HealthCare Technologies Inc.
  • Eurofins Genomics LLC

第31章 その他の大手および革新的な企業

• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Qiagen NV
• Sigma-Aldrich Corporation
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Promega Corporation
• GenScript Biotech Corporation
• Integrated DNA Technologies Inc.
• LGC Ltd.
• Sequenom Inc.
• Fluidigm Corporation
• Agendia Inc.
• Nugen Technologies Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Single nucleotide polymorphism (SNP) genotyping is a procedure that identifies and describes genetic variants at the level of specific DNA nucleotides. It focuses on pinpointing individual SNPs, which are single-base changes in DNA sequences. This process is crucial for gaining insights into genetic variations associated with diseases, traits, and population studies.

The primary products of single nucleotide polymorphism (SNP) genotyping include consumables, instruments, and services. Consumables refer to items that people and businesses regularly consume or use up, requiring replacement, such as food and home supplies. Various technologies are employed in SNP genotyping, including TaqMan SNP genotyping, Mass Array SNP genotyping, SNP gene chip arrays, and others. These technologies find applications in diverse fields such as animal genetics, plant improvement, diagnostic research, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and more.

The single nucleotide polymorphism (SNP) genotyping market research report is one of a series of new reports from The Business Research Company that provides single nucleotide polymorphism (SNP) genotyping market statistics, including the single nucleotide polymorphism (SNP) genotyping industry's global market size, regional shares, competitors with a single nucleotide polymorphism (SNP) genotyping market share, detailed single nucleotide polymorphism (SNP) genotyping market segments, market trends and opportunities, and any further data you may need to thrive in the single nucleotide polymorphism (SNP) genotyping industry. This single nucleotide polymorphism (SNP) genotyping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The single nucleotide polymorphism (snp) genotyping market size has grown exponentially in recent years. It will grow from $8.48 billion in 2023 to $10.24 billion in 2024 at a compound annual growth rate (CAGR) of 20.7%. The expansion during the historical period can be attributed to increasing research in genomics, a rise in genetic disorders, growth in personalized medicine, the expanding pharmaceutical industry, and rising demand for molecular diagnostics.

The single nucleotide polymorphism (snp) genotyping market size is expected to see rapid growth in the next few years. It will grow to $20.6 billion in 2028 at a compound annual growth rate (CAGR) of 19.1%. The anticipated growth in the forecast period can be attributed to growing applications in disease research, a rise in demand for precision medicine, expanding biobanking initiatives, a surge in genetic testing, and rising adoption in agriculture for crop improvement. Key trends expected in the forecast period include the increasing use of next-generation sequencing (NGS), rising demand for SNP genotyping in pharmacogenomics, the emergence of direct-to-consumer genetic testing, and a focus on automation and high-throughput genotyping platforms.

The growth of the single nucleotide polymorphism (SNP) genotyping market is anticipated to be driven by the increasing burden of chronic conditions. Chronic conditions, defined as ailments lasting a year or more and requiring ongoing medical care, significantly impact daily activities. Single Nucleotide Polymorphism (SNP) genotyping plays a crucial role in identifying genetic predispositions, contributing to the rise of personalized medicine amidst the growing prevalence of chronic diseases. As indicated by the National Center for Biotechnology Information (NCBI) in January 2023, the global number of individuals with chronic diseases is projected to reach 142.66 million by 2050, up from 71.522 million in 2020. This escalation in the burden of chronic conditions is a key factor propelling the growth of the single nucleotide polymorphism (SNP) genotyping systems market.

The increasing allocation of funds for genomic research is poised to further boost the growth of the single nucleotide polymorphism (SNP) genotyping market. Funds for genomic research encompass financial resources dedicated to supporting research activities in genomics, crucial for advancing SNP studies. Organizations such as the National Human Genome Research Institute received $604 million in 2020, $614 million in 2021, and $616 million in 2022, with a proposed budget of $629 million for 2023. Additionally, the Biden administration allocated $1.7 billion in April 2021 to enhance SARS-CoV-2 variant detection, monitoring, and mitigation, emphasizing the establishment of genomic sequencing infrastructure. This rise in funds for genomic research is a significant driver of the single nucleotide polymorphism (SNP) genotyping market.

A prominent trend in the single nucleotide polymorphism (SNP) genotyping market is the adoption of technological solutions. Major companies in this market are introducing advanced solutions to maintain their market position. For instance, in May 2022, Neogen Corporation and Gencove launched InfiniSEEK, the first complete genome and genotyping tool for cattle breeders. InfiniSEEK's validation demonstrates high concordance with deep whole-genome sequencing, providing clinical-grade accuracy in specific areas of interest. This technological advancement underscores the commitment of companies to bring innovative solutions to the single nucleotide polymorphism (SNP) genotyping market.

Companies in the single nucleotide polymorphism (SNP) genotyping market are also focusing on developing biomarkers for coronary heart disease detection, enhancing market profitability. Single nucleotide polymorphism (SNP) biomarkers associated with coronary heart disease (CHD) detection are genetic variations linked to an increased risk of CHD. For instance, Cardio Diagnostics launched PrecisionCHD in February 2023, an AI-driven blood test utilizing epigenetic and genetic biomarkers to detect CHD. This non-invasive test eliminates the need for traditional methods, providing objectivity through biomarkers rather than self-reported patient data.

In July 2021, DiaSorin S.p.A. acquired Luminex Corporation for approximately $1.8 billion. This strategic move aims to broaden the applications of Luminex across the Life Science sector, strengthening collaboration with the biopharmaceutical industry and enhancing the availability of clinical multiplexing assays. Luminex Corporation, a US-based biotechnology company, specializes in single nucleotide polymorphism (SNP) genotyping technology.

Major companies operating in the single nucleotide polymorphism (snp) genotyping market report are Thermo Fisher Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.

North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (snp) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single nucleotide polymorphism (snp) genotyping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single nucleotide polymorphism (SNP) genotyping market includes revenues earned by providing sample collection, DNA extraction, high-resolution melting analysis, and related next-generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The single nucleotide polymorphism (SNP) genotyping market consists of sales of mass spectrometry-based SNP genotyping and allele-specific PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single nucleotide polymorphism (snp) genotyping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single nucleotide polymorphism (snp) genotyping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The single nucleotide polymorphism (snp) genotyping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Consumables; Instruments; services
• 2) By Technology: TaqMan SNP Genotyping; Mass Array SNP Genotyping; SNP Gene Chip Arrays; Other Technologies
• 3) By Application: Animal Genetics; Plant Improvement; Diagnostic Research; Pharmaceuticals And Pharmacogenomics; Agricultural Biotechnology; Other Applications
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Roche Diagnostics Corporation; GE HealthCare Technologies Inc.; Eurofins Genomics LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Single Nucleotide Polymorphism (SNP) Genotyping Market Characteristics

3. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends And Strategies

4. Single Nucleotide Polymorphism (SNP) Genotyping Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth

• 5.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation

• 6.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Consumables
• Instruments
• Services
• 6.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• TaqMan SNP Genotyping
• Mass Array SNP Genotyping
• SNP Gene Chip Arrays
• Other Technologies
• 6.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Animal Genetics
• Plant Improvement
• Diagnostic Research
• Pharmaceuticals And Pharmacogenomics
• Agricultural Biotechnology
• Other Applications

7. Single Nucleotide Polymorphism (SNP) Genotyping Market Regional And Country Analysis

• 7.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market

• 8.1. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Single Nucleotide Polymorphism (SNP) Genotyping Market

• 9.1. China Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 9.2. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Single Nucleotide Polymorphism (SNP) Genotyping Market

• 10.1. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market

• 11.1. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 11.2. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market

• 12.1. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market

• 13.1. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market

• 14.1. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 14.2. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market

• 15.1. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 15.2. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Single Nucleotide Polymorphism (SNP) Genotyping Market

• 16.1. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market

• 17.1. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Single Nucleotide Polymorphism (SNP) Genotyping Market

• 18.1. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market

• 19.1. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market

• 20.1. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market

• 21.1. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 21.2. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market

• 22.1. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Single Nucleotide Polymorphism (SNP) Genotyping Market

• 23.1. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 23.2. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Single Nucleotide Polymorphism (SNP) Genotyping Market

• 24.1. USA Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 24.2. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market

• 25.1. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 25.2. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Single Nucleotide Polymorphism (SNP) Genotyping Market

• 26.1. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 26.2. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market

• 27.1. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market

• 28.1. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 28.2. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market

• 29.1. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 29.2. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape And Company Profiles

• 30.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape
• 30.2. Single Nucleotide Polymorphism (SNP) Genotyping Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Danaher Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Roche Diagnostics Corporation
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GE HealthCare Technologies Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Eurofins Genomics LLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Single Nucleotide Polymorphism (SNP) Genotyping Market Other Major And Innovative Companies

• 31.1. Beckman Coulter Inc.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Qiagen N.V.
• 31.4. Sigma-Aldrich Corporation
• 31.5. Agilent Technologies Inc.
• 31.6. PerkinElmer Inc.
• 31.7. Illumina Inc.
• 31.8. Promega Corporation
• 31.9. GenScript Biotech Corporation
• 31.10. Integrated DNA Technologies Inc.
• 31.11. LGC Ltd.
• 31.12. Sequenom Inc.
• 31.13. Fluidigm Corporation
• 31.14. Agendia Inc.
• 31.15. Nugen Technologies Inc.

32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Benchmarking

33. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Single Nucleotide Polymorphism (SNP) Genotyping Market

35. Single Nucleotide Polymorphism (SNP) Genotyping Market Future Outlook and Potential Analysis

• 35.1 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer